Amedisys stock drops 6% after report DOJ may challenge UnitedHealthcare acquisition. Traders cite Capitol Forum report.
Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback